- Diabetes, Obesity and Metabolism
- Overcoming Therapeutic Inertia as the Achilles’ Heel for Improving Suboptimal Diabetes Care: An Integrative Review
-
Boon-How Chew, Barakatun-Nisak Mohd-Yusof, Pauline Siew Mei Lai, Kamlesh Khunti
-
Endocrinol Metab. 2023;38(1):34-42. Published online February 16, 2023
-
DOI: https://doi.org/10.3803/EnM.2022.1649
-
-
5,051
View
-
282
Download
-
5
Web of Science
-
6
Crossref
-
Abstract
PDF PubReader ePub
- The ultimate purpose of diabetes care is achieving the outcomes that patients regard as important throughout the life course. Despite advances in pharmaceuticals, nutraceuticals, psychoeducational programs, information technologies, and digital health, the levels of treatment target achievement in people with diabetes mellitus (DM) have remained suboptimal. This clinical care of people with DM is highly challenging, complex, costly, and confounded for patients, physicians, and healthcare systems. One key underlying problem is clinical inertia in general and therapeutic inertia (TI) in particular. TI refers to healthcare providers’ failure to modify therapy appropriately when treatment goals are not met. TI therefore relates to the prescribing decisions made by healthcare professionals, such as doctors, nurses, and pharmacists. The known causes of TI include factors at the level of the physician (50%), patient (30%), and health system (20%). Although TI is often multifactorial, the literature suggests that 28% of strategies are targeted at multiple levels of causes, 38% at the patient level, 26% at the healthcare professional level, and only 8% at the healthcare system level. The most effective interventions against TI are shorter intervals until revisit appointments and empowering nurses, diabetes educators, and pharmacists to review treatments and modify prescriptions.
-
Citations
Citations to this article as recorded by 
- Efficient and Effective Diabetes Care in the Era of Digitalization and Hypercompetitive Research Culture: A Focused Review in the Western Pacific Region with Malaysia as a Case Study
Boon-How Chew, Pauline Siew Mei Lai, Dhashani A/P Sivaratnam, Nurul Iftida Basri, Geeta Appannah, Barakatun Nisak Mohd Yusof, Subashini C. Thambiah, Zubaidah Nor Hanipah, Ping-Foo Wong, Li-Cheng Chang Health Systems & Reform.2025;[Epub] CrossRef - Clinical control in COPD and therapeutic implications: The EPOCONSUL audit
Myriam Calle Rubio, Marc Miravitlles, Juan José Soler Cataluña, José Luis López-Campos, Bernardino Alcázar Navarrete, Manuel E. Fuentes Ferrer, Juan Luis Rodríguez Hermosa, Stelios Loukides PLOS ONE.2025; 20(1): e0314299. CrossRef - Association between sex, age, temporal trends, and glycemic control of 221,769 adults with type 2 diabetes in a multi-ethnic middle-income Asian country
Swee Hung Ang, Lee-Ling Lim, Feisul Idzwan Mustapha, Eliana Ahmad, Sanjay Rampal Diabetes Research and Clinical Practice.2025; 220: 111976. CrossRef - Obesity management from the perspectives of people living with obesity in Canada: A mixed‐methods study
David C. W. Lau, Ian Patton, Reena Lavji, Adel Belloum, Ginnie Ng, Renuca Modi Diabetes, Obesity and Metabolism.2024; 26(4): 1529. CrossRef - Using continuous glucose monitoring to measure and improve quality metrics: Updates on the Healthcare Effectiveness Data and Information Set 2024 Glucose Management Indicator measure
Marissa Morris-Murray, Marie Frazzitta Journal of Managed Care & Specialty Pharmacy.2024; 30(10-b Suppl): S30. CrossRef - Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André J Scheen Expert Review of Clinical Pharmacology.2023; 16(11): 1053. CrossRef
|